Hypoxia regulate developmental coronary angiogenesis potentially through VEGF ‐ R2 ‐ and SOX17 ‐mediated signaling
Developmental Dynamics · 2025
DOI: 10.1002/dvdy.750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Dynamics, 2025. Verfasst von Halie E Vitali und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Ball State University, Muncie, Indiana, USA. Hauptthemen laut MEDLINE: SOXF Transcription Factors, Signal Transduction, Neovascularization, Physiologic, Coronary Vessels. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
The development of coronary vessels in embryonic mouse heart involves various progenitor populations, including sinus venosus (SV), endocardium, and proepicardium. ELA/APJ signaling is known to regulate coronary growth from the SV, whereas VEGF‐A/VEGF‐R2 signaling controls growth from the endocardium. Previous studies suggest hypoxia might regulate coronary growth, but its specific downstream pathways are unclear. In this study, we further investigated the role of hypoxia and have identified SOX17‐ and VEGF‐R2‐mediated signaling as the potential downstream pathways in its regulation of developmental coronary angiogenesis.
Results
HIF‐1α stabilization by knocking out von Hippel Lindau (VHL) protein in the myocardium (cKO) disrupted normal coronary angiogenesis in embryonic mouse hearts, resembling patterns of accelerated coronary growth. VEGF‐R2 expression was increased in coronary endothelial cells under hypoxia in vitro and in VHL cKO hearts in vivo. Similarly, SOX17 expression was increased in the VHL cKO hearts, while its knockout in the endocardium disrupted normal coronary growth.
Conclusion
These findings provide further evidence that hypoxia regulates developmental coronary growth potentially through VEGF‐R2 and SOX17 pathways, shedding light on mechanisms of coronary vessel development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Ball State University, Muncie, Indiana, USA.
- Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, New Jersey, USA.
ORCID-Profile: Bikram Sharma
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Vitali, H. E., Kuschel, B., Sherpa, C., Jones, B. W., Jacob, N., Madiha, S. A., Elliott, S., Dziennik, E., Kreun, L., Conatser, C., Bhetwal, B. P., & Sharma, B. (2025). Hypoxia regulate developmental coronary angiogenesis potentially through VEGF ‐ R2 ‐ and SOX17 ‐mediated signaling. Developmental Dynamics. https://doi.org/10.1002/dvdy.750
Vancouver
Vitali HE, Kuschel B, Sherpa C, Jones BW, Jacob N, Madiha SA, et al. Hypoxia regulate developmental coronary angiogenesis potentially through VEGF ‐ R2 ‐ and SOX17 ‐mediated signaling. Developmental Dynamics. 2025. doi:10.1002/dvdy.750
BibTeX
@article{Vitali2025,
author = {Vitali, Halie E and Kuschel, Bryce and Sherpa, Chhiring and Jones, Brendan W and Jacob, Nisha and Madiha, Syeda A and Elliott, Sam and Dziennik, Eddie and Kreun, Lily and Conatser, Cora and Bhetwal, Bhupal P and Sharma, Bikram},
title = {Hypoxia regulate developmental coronary angiogenesis potentially through VEGF ‐ R2 ‐ and SOX17 ‐mediated signaling},
journal = {Developmental Dynamics},
year = {2025},
doi = {10.1002/dvdy.750}
}
EUVIMED